Medicare Enrolled
Dr. William Naguszewski, M.D.
Neurology · Rome, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Naguszewski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naguszewski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Naguszewski
Dr. William Naguszewski is a neurology specialist in Rome, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Naguszewski performed 8,341 Medicare services across 911 unique beneficiaries.
Between the years covered by Open Payments, Dr. Naguszewski received a total of $16,780 from 84 pharmaceutical and/or device companies across 897 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Naguszewski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in GA
$16,780 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,341
Medicare services
Top 12% in GA for neurology
911
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~417 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
7,200 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
494 | $82 | $134 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
278 | $55 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
84 | $103 | $181 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $125 | $184 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
45 | $44 | $103 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
33 | $94 | $154 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
24 | $73 | $130 |
| New patient office visit, complex (60-74 min) | 23 | $127 | $234 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
18 | $174 | $282 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $75 | $122 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
14 | $405 | $879 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
13 | $35 | $112 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
11 | $410 | $675 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
11 | $321 | $524 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,780
Total received (2018-2024)
Avg $2,397/year across 7 years
Top 18% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
897
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,074 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$706 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,716
2023
$3,356
2022
$3,060
2021
$2,790
2020
$1,335
2019
$1,109
2018
$1,414
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$500
JAZZ PHARMACEUTICALS INC.
$336
PFIZER INC.
$298
HARMONY BIOSCIENCES LLC
$251
MDD US Operations, LLC
$229
Biogen, Inc.
$209
UCB, Inc.
$162
TG Therapeutics, Inc.
$139
Harmony Biosciences Llc
$134
Avadel CNS Pharmaceuticals, LLC
$118
Eisai Inc.
$111
Novartis Pharmaceuticals Corporation
$106
ARGENX US, INC.
$99
Lilly USA, LLC
$82
Amneal Pharmaceuticals LLC
$80
Neurelis, Inc.
$67
CATALYST PHARMACEUTICALS, INC.
$66
Neurocrine Biosciences, Inc.
$60
Otsuka America Pharmaceutical, Inc.
$58
Lundbeck LLC
$55
Kyowa Kirin, Inc.
$53
Sumitomo Pharma America, Inc.
$52
SK Life Science, Inc.
$46
ANI Pharmaceuticals, Inc.
$46
Vanda Pharmaceuticals Inc.
$42
Alexion Pharmaceuticals, Inc.
$41
Amgen Inc.
$39
Teva Pharmaceuticals USA, Inc.
$36
Genentech USA, Inc.
$34
CSL Behring
$29
Xeris Pharmaceuticals, Inc.
$22
Axsome Therapeutics, Inc.
$22
Inspire Medical Systems, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
ACADIA Pharmaceuticals Inc
$20
Octapharma USA, Inc.
$18
Resmed Corp
$15
Top 3 companies account for 30.5% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,486
ABBVIE INC.
$1,192
Supernus Pharmaceuticals, Inc.
$913
Teva Pharmaceuticals USA, Inc.
$872
UCB, Inc.
$867
Harmony Biosciences LLC
$617
LivaNova USA, Inc.
$602
JAZZ PHARMACEUTICALS INC.
$579
PFIZER INC.
$543
Novartis Pharmaceuticals Corporation
$438
HARMONY BIOSCIENCES LLC
$384
Amneal Pharmaceuticals LLC
$363
Lilly USA, LLC
$342
AbbVie Inc.
$316
MDD US Operations, LLC
$308
Eisai Inc.
$307
Lundbeck LLC
$284
Neurelis, Inc.
$284
Amgen Inc.
$263
IMPEL PHARMACEUTICALS INC.
$257
Avanir Pharmaceuticals, Inc.
$257
Biohaven Pharmaceutical Holding Company Ltd.
$253
ARGENX US, INC.
$237
SK Life Science, Inc.
$214
Neurocrine Biosciences, Inc.
$212
Genentech USA, Inc.
$196
ACADIA Pharmaceuticals Inc
$196
UPSHER-SMITH LABORATORIES LLC
$192
Kyowa Kirin, Inc.
$191
Alexion Pharmaceuticals, Inc.
$188
Jazz Pharmaceuticals Inc.
$181
Allergan Inc.
$174
Alnylam Pharmaceuticals Inc.
$157
Sunovion Pharmaceuticals Inc.
$154
TG Therapeutics, Inc.
$139
Otsuka America Pharmaceutical, Inc.
$138
Allergan, Inc.
$135
Harmony Biosciences Llc
$134
CSL Behring
$125
Boston Scientific Corporation
$122
Avadel CNS Pharmaceuticals, LLC
$118
Greenwich Biosciences, Inc.
$110
Mallinckrodt Hospital Products Inc.
$106
Janssen Pharmaceuticals, Inc
$92
Axsome Therapeutics, Inc.
$92
Avion Pharmaceuticals
$91
Acorda Therapeutics, Inc
$85
BANNER LIFE SCIENCES, LLC
$78
Upsher-Smith Laboratories LLC
$75
CATALYST PHARMACEUTICALS, INC.
$66
Xeris Pharmaceuticals, Inc.
$63
IDORSIA PHARMACEUTICALS US INC
$62
Vanda Pharmaceuticals Inc.
$59
EISAI INC.
$55
Corium, LLC
$53
Biohaven Pharmaceuticals, Inc.
$53
Sumitomo Pharma America, Inc.
$52
ANI Pharmaceuticals, Inc.
$46
AstraZeneca Pharmaceuticals LP
$43
TG THERAPEUTICS, INC.
$42
GENZYME CORPORATION
$40
Bausch Health US, LLC
$39
EMD Serono, Inc.
$38
Octapharma USA, Inc.
$35
Merz Pharmaceuticals, LLC
$31
Resmed Corp
$30
Otsuka Pharmaceutical Development & Commercialization, Inc.
$25
Impax Laboratories, Inc.
$23
Inspire Medical Systems, Inc.
$21
Catalyst Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$20
Horizon Therapeutics plc
$19
Adamas Pharmaceuticals, Inc.
$19
Marinus Pharmaceuticals, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
AQUESTIVE THERAPEUTICS, INC.
$16
Banner Life Sciences, LLC
$16
Arbor Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme Corporation
$15
Scilex Pharmaceuticals Inc.
$15
Strongbridge US INC.
$13
OWP Pharmaceuticals, Inc.
$13
US WorldMeds, LLC
$12
Top 3 companies account for 21.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AIRSENSE · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · CREXONT · DUOPA · Dayvigo · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FYCOMPA · Fycompa · GILENYA · GOCOVRI · GVOKE PFS · General - Pain Management · Gocovri · HETLIOZ · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KEVEYIS · LINZESS · LUMRYZ · Lamotrigine Starter Kit · Leqembi · MAYZENT · MIGRANAL · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · Sunosi · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XYREM · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZTALMY · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
7
Per 100K population
7.1
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
8.8 mi
8.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Naguszewski is a mixed practice specialist, with above-average Medicare volume (top 12% in GA), with low-engagement industry engagement in the top 18% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Naguszewski experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Naguszewski performed 7,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naguszewski receive payments from pharmaceutical companies?
Yes. Dr. Naguszewski received a total of $16,780 from 84 companies across 897 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naguszewski's costs compare to other neurologists in Rome?
Dr. Naguszewski's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naguszewski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rome
Browse neurologists in Rome ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology